Nasopharyngeal carcinoma of the undifferentiated subtype is endemic to southern China,
and patient prognosis has improved significantly over the past three decades because of …

Nasopharyngeal carcinoma (NPC) is closely associated with Epstein-Barr virus (EBV) and
occurs frequently in the south of China and Southeast Asian countries. Concurrent chemo …

Management of nasopharyngeal carcinoma is one of the greatest clinical challenges.
Appropriate detection is not easy because of its anatomical location; sensitive biomarkers in …

Background To test the hypothesis that prognostication of treatment outcome is feasible by
biomarker response at midcourse of chemoradiotherapy (CRT)/radiotherapy (RT), with …

This is a review of the evolving efforts to understand and combat nasopharyngeal carcinoma
(NPC), a most peculiar cancer with a distinctly skewed geographic and ethnic distribution …

Molecular signaling in the tumor microenvironment (TME) is complex, and crosstalk among
various cell compartments in supporting metastasis remains poorly understood. In particular …

Background The purpose of this clinical review was to summate the published data for the
long‐term outcomes of reirradiation with intensity‐modulated radiotherapy (IMRT) for locally …

Nasopharyngeal carcinoma is endemic in Asia and is etiologically associated with Epstein–
Barr virus. Radiotherapy is the primary treatment modality. The role of systemic therapy has …

Nasopharyngeal carcinoma (NPC) is a severe malignancy arising from the nasopharyngeal
epithelium and is southern China's third most common cancer. With the advancement of …

Nasopharyngeal carcinoma (NPC) is a common malignant tumor in Southern China and
South-East Asia. Regardless of initiative high response to radiotherapy, parts of patients still …